WorldCat Identities

Grech, Louise

Overview
Works: 4 works in 17 publications in 1 language and 255 library holdings
Roles: Editor, Author, htt
Classifications: RC933, 616.7227061
Publication Timeline
.
Most widely held works by Louise Grech
Pharmaceutical care issues of patients with rheumatoid arthritis : from hospital to community by Louise Grech( )

14 editions published between 2016 and 2018 in English and held by 250 WorldCat member libraries worldwide

This book presents concise, comprehensive summaries of topics necessary to understand rheumatoid arthritis (RA) management, aligned with patient needs, as a reference suitable for practitioners and students of all levels. Special attention is paid to the innovative RhMAT (Rheumatoid Arthritis Medication Assessment Tool), in addition to descriptions of the pharmacological management of RA, pharmacoeconomic and pharmacovigilance considerations, the benefits of seamless care, and case presentations. Rheumatoid arthritis is one of the most common forms of inflammatory arthritis in the world, with a prevalence of 0.5 to 1%. While no cure has yet been established, modern biotechnology has enabled highly effective management, if treatment begins early. However, cost and side effects, such as immune suppression, continue to present barriers, and monitoring of patients is pivotal to safe and effective disease management. Both hospital and community pharmacists are involved in RA patient management, and have responsibilities to this patient population. Identifying pharmaceutical care issues and ensuring that the patients are managed in accordance to best evidence-based medicine are paramount. Best care is delivered when pharmacists effectively communicate with each other, the prescribers and the multidisciplinary team members involved in the care of the patient. This book aims to tackle the various aspects of the management of RA patients across all the settings
Chronopharmacology in Hypertension The case of Valsartan and Amlodipine by Sephorah Falzon( )

1 edition published in 2018 in English and held by 2 WorldCat member libraries worldwide

A Pharmaceutical Care Model for Patients with Rheumatoid Arthritis by Louise Grech( )

1 edition published in 2018 in English and held by 2 WorldCat member libraries worldwide

Development and validation of RhMAT, as medication assessment tool specifically designed for rheumatoid arthritis management( )

1 edition published in 2015 in English and held by 1 WorldCat member library worldwide

Abstract: Objectives: The implementation of individualised pharmaceutical care plans based on the identification of pharmaceutical care issues for rheumatoid arthritis patients presenting at outpatient clinic service has been proven to be effective in improving the quality of life of these patients. However, the identification and classification of pharmaceutical care issues into drug therapy problems does not give room to assessment of prescribing trends and adherence to international guidelines. The novel concept of medication assessment tools, is a concept which integrates pharmaceutical care issues within a larger context, that of evaluating the prescribing trends. The objective of this research was to design, and validate medication assessment tools specifically for rheumatoid arthritis patients. Methods: A thorough literature review was carried out to identify the latest evidence-based guidelines on rheumatoid arthritis pharmacotherapy. The rheumatoid arthritis medication assessment tool (RhMAT) was compiled and validated. Key findings: The RhMAT consists of 11 general sections with a total of 54 criteria. For every criteria given, the researcher has an option of four responses ranging from criterion not applicable (N/A), criterion adherence (yes), criterion non-adherence (no) and insufficient data to comment on the criterion. In cases where the criterion is not adhered to this can be justified adherence or unjustified and insufficient data for the researcher to be able to tick appropriately. The expert panel agreed with the final version of the RhMAT. Conclusion: The innovative RhMAT was designed to act as a tool used by pharmacists to be able to detect gaps within patients' pharmacotherapy against evidence-based guidelines thereby improving the quality of service offered to patients
 
Audience Level
0
Audience Level
1
  General Special  
Audience level: 0.52 (from 0.51 for A Pharmace ... to 0.97 for A Pharmace ...)

Pharmaceutical care issues of patients with rheumatoid arthritis : from hospital to community
Covers
Languages
English (17)